Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Kent State Faculty and Students Research the Use of Weight Bearing CT to Effectively Assess Magnitude of Hallux Valgus Deformity

Hallux valgus is a triplane deformity. In patients with this deformity, the sesamoids displace from their normal alignment. Recent evidence suggests that, according to researchers, “the magnitude of this displacement can be determined by the coronal plane sesamoid rotation angle.” Podiatric doctors often use weight-bearing radiographs to determine the magnitude of the hallux valgus deformity. This…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Hallux valgus is a triplane deformity. In patients with this deformity, the sesamoids displace from their normal alignment. Recent evidence suggests that, according to researchers, “the magnitude of this displacement can be determined by the coronal plane sesamoid rotation angle.” Podiatric doctors often use weight-bearing radiographs to determine the magnitude of the hallux valgus deformity. This is a crucial step in planning surgical correction. However, conventional foot radiographs have long been problematic due to:

  • geometric distortion
  • unreliable measurements made between different observers
  • limited imaging in the coronal plane
  • measurable differences between weight-bearing and non-weight-bearing images

CT scanning addresses these problems. It allows “cross-sectional imaging of the anatomical parts in all three planes of the foot without typical radiographic distortion.” In other words, doctors are able to look at slices of the foot for better data. CT scanners also allow for three-dimensional reconstruction of the foot.

The Kent State University College of Podiatic Medicine recently acquired a CurveBeam pedCAT bilateral weight-bearing CT scanner via a grant funded by the Ohio College of Podiatric Medicine (OCPM) Foundation. In the wake of this acquisition, the College of Podiatric Medicine students and faculty proposed three research projects. Each one has the potential to break new ground in the specialty. A team of KSUCPM researchers has completed the first project, which focuses on the evaluation of hallux valgus deformity in the coronal plane of the foot.

Differences in Rotation Angle Between Two Extreme Weight-Bearing Positions

Using the weight-bearing CT scanner, this study was designed to determine, according to the researchers, “the effect of different weight-bearing foot positions on the coronal plane sesamoid rotation angle as compared with standard sesamoid axial studies.” Study data demonstrated “significant differences in the rotation angle between the two extreme weight-bearing positions.” Sesamoid rotation angles, the researchers noted, were “significantly higher in the pronated foot position.” Sesamoid rotation angles from the weight-bearing CT supinated position correlated with those values.

Weight-Bearing CT Scan Determination Should Replace Forefoot Axial Studies

These results strongly suggest that “weight-bearing CT scan determination with the foot in a non-affected weight-bearing position should replace forefoot axial studies as the accepted imaging standard.”

Learn more about how Weight-Bearing CT in diagnosing Hallux Valgus patients here.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512